RaPID discovery of cell-permeable helical peptide inhibitors con-taining cyclic β-amino acids against SARS-CoV-2 main protease

Marina Kawai, Tika R. Malla, H. T. Henry Chan, Anthony Tumber, Lennart Brewitz, Eidarus Salah, Naohiro Terasaka, Takayuki Katoh, Akane Kawamura, Christopher J. Schofield, Fernanda Duarte and Hiroaki Suga

RSC Chem. Biol., 2025, 6, 1089
DOI: 10.1039/D5CB00021A

On the origins of SARS-CoV-2 main protease inhibitors

Yves L. Janin

RSC Med. Chem., 2024, 15, 81
DOI: 10.1039/D3MD00493G

Studies on the selectivity of the SARS-CoV-2 papain-like protease reveal the importance of the P2′ proline of the viral polyprotein

H. T. Henry Chan, Lennart Brewitz, Petra Lukacik, Claire Strain-Damerell, Martin A. Walsh, Christopher J. Schofield and Fernanda Duarte

RSC Chem. Biol., 2024, 5, 117
DOI: 10.1039/D3CB00128H

β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates

Montserrat Mora-Ochomogo and Christopher T. Lohans

RSC Med. Chem., 2021, 12, 1623
DOI: 10.1039/D1MD00200G

Thiophene-fused γ-lactams inhibit the SARS-CoV-2 main protease via reversible covalent acylation

Gayatri, Lennart Brewitz, Lewis Ibbotson, Eidarus Salah, Shyam Basak, Hani Choudhry and Christopher J. Schofield

Chem. Sci., 2024, 15, 7667
DOI: 10.1039/D4SC01027B

Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding

H. T. Henry Chan, Marc A. Moesser, Rebecca K. Walters, Tika R. Malla, Rebecca M. Twidale, Tobias John, Helen M. Deeks, Tristan Johnston-Wood, Victor Mikhailov, Richard B. Sessions, William Dawson, Eidarus Salah, Petra Lukacik, Claire Strain-Damerell, C. David Owen, Takahito Nakajima, Katarzyna Świderek, Alessio Lodola, Vicent Moliner, David R. Glowacki, James Spencer, Martin A. Walsh, Christopher J. Schofield, Luigi Genovese, Deborah K. Shoemark, Adrian J. Mulholland, Fernanda Duarte and Garrett M. Morris

Chem. Sci., 2021, 12, 13686
DOI: 10.1039/D1SC03628A

Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease

Takashi Miura, Tika R Malla, Lennart Brewitz, Anthony Tumber, Eidarus Salah, Kang Ju Lee, Naohiro Terasaka, C David Owen, Claire Strain-Damerell, Petra Lukacik, Martin A Walsh, Akane Kawamura, Christopher J Schofield, Takayuki Katoh and Hiroaki Suga

Bulletin of the Chemical Society of Japan, 2024, 97
DOI: 10.1093/bulcsj/uoae018

Proteolytic reaction-based versatile electrochemical biosensor chip for simple and quantitative point-of-care testing

Seonhwa Park, Gyeongho Kim and Haesik Yang

Sensors and Actuators B: Chemical, 2024, 414, 135934
DOI: 10.1016/j.snb.2024.135934

Mass spectrometric assays monitoring the deubiquitinase activity of the SARS-CoV-2 papain-like protease inform on the basis of substrate selectivity and have utility for substrate identification

Lennart Brewitz, H.T. Henry Chan, Petra Lukacik, Claire Strain-Damerell, Martin A. Walsh, Fernanda Duarte and Christopher J. Schofield

Bioorganic & Medicinal Chemistry, 2023, 95, 117498
DOI: 10.1016/j.bmc.2023.117498

Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease

Lennart Brewitz, Jos J. A. G. Kamps, Petra Lukacik, Claire Strain‐Damerell, Yilin Zhao, Anthony Tumber, Tika R. Malla, Allen M. Orville, Martin A. Walsh and Christopher J. Schofield

ChemMedChem, 2022, 17
DOI: 10.1002/cmdc.202200016

Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review

Xin Li and Yongcheng Song

European Journal of Medicinal Chemistry, 2023, 260, 115772
DOI: 10.1016/j.ejmech.2023.115772

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Melissa L. Boby, Daren Fearon, Matteo Ferla, Mihajlo Filep, Lizbé Koekemoer, Matthew C. Robinson, John D. Chodera, Alpha A. Lee, Nir London, Annette von Delft, Frank von Delft, Hagit Achdout, Anthony Aimon, Dominic S. Alonzi, Robert Arbon, Jasmin C. Aschenbrenner, Blake H. Balcomb, Elad Bar-David, Haim Barr, Amir Ben-Shmuel, James Bennett, Vitaliy A. Bilenko, Bruce Borden, Pascale Boulet, Gregory R. Bowman, Lennart Brewitz, Juliane Brun, Sarma BVNBS, Mark Calmiano, Anna Carbery, Daniel W. Carney, Emma Cattermole, Edcon Chang, Eugene Chernyshenko, Austin Clyde, Joseph E. Coffland, Galit Cohen, Jason C. Cole, Alessandro Contini, Lisa Cox, Tristan Ian Croll, Milan Cvitkovic, Steven De Jonghe, Alex Dias, Kim Donckers, David L. Dotson, Alice Douangamath, Shirly Duberstein, Tim Dudgeon, Louise E. Dunnett, Peter Eastman, Noam Erez, Charles J. Eyermann, Michael Fairhead, Gwen Fate, Oleg Fedorov, Rafaela S. Fernandes, Lori Ferrins, Richard Foster, Holly Foster, Laurent Fraisse, Ronen Gabizon, Adolfo García-Sastre, Victor O. Gawriljuk, Paul Gehrtz, Carina Gileadi, Charline Giroud, William G. Glass, Robert C. Glen, Itai Glinert, Andre S. Godoy, Marian Gorichko, Tyler Gorrie-Stone, Ed J. Griffen, Amna Haneef, Storm Hassell Hart, Jag Heer, Michael Henry, Michelle Hill, Sam Horrell, Qiu Yu Judy Huang, Victor D. Huliak, Matthew F. D. Hurley, Tomer Israely, Andrew Jajack, Jitske Jansen, Eric Jnoff, Dirk Jochmans, Tobias John, Benjamin Kaminow, Lulu Kang, Anastassia L. Kantsadi, Peter W. Kenny, J. L. Kiappes, Serhii O. Kinakh, Boris Kovar, Tobias Krojer, Van Ngoc Thuy La, Sophie Laghnimi-Hahn, Bruce A. Lefker, Haim Levy, Ryan M. Lithgo, Ivan G. Logvinenko, Petra Lukacik, Hannah Bruce Macdonald, Elizabeth M. MacLean, Laetitia L. Makower, Tika R. Malla, Peter G. Marples, Tatiana Matviiuk, Willam McCorkindale, Briana L. McGovern, Sharon Melamed, Kostiantyn P. Melnykov, Oleg Michurin, Pascal Miesen, Halina Mikolajek, Bruce F. Milne, David Minh, Aaron Morris, Garrett M. Morris, Melody Jane Morwitzer, Demetri Moustakas, Charles E. Mowbray, Aline M. Nakamura, Jose Brandao Neto, Johan Neyts, Luong Nguyen, Gabriela D. Noske, Vladas Oleinikovas, Glaucius Oliva, Gijs J. Overheul, C. David Owen, Ruby Pai, Jin Pan, Nir Paran, Alexander Matthew Payne, Benjamin Perry, Maneesh Pingle, Jakir Pinjari, Boaz Politi, Ailsa Powell, Vladimír Pšenák, Iván Pulido, Reut Puni, Victor L. Rangel, Rambabu N. Reddi, Paul Rees, St Patrick Reid, Lauren Reid, Efrat Resnick, Emily Grace Ripka, Ralph P. Robinson, Jaime Rodriguez-Guerra, Romel Rosales, Dominic A. Rufa, Kadi Saar, Kumar Singh Saikatendu, Eidarus Salah, David Schaller, Jenke Scheen, Celia A. Schiffer, Christopher J. Schofield, Mikhail Shafeev, Aarif Shaikh, Ala M. Shaqra, Jiye Shi, Khriesto Shurrush, Sukrit Singh, Assa Sittner, Peter Sjö, Rachael Skyner, Adam Smalley, Bart Smeets, Mihaela D. Smilova, Leonardo J. Solmesky, John Spencer, Claire Strain-Damerell, Vishwanath Swamy, Hadas Tamir, Jenny C. Taylor, Rachael E. Tennant, Warren Thompson, Andrew Thompson, Susana Tomásio, Charles W. E. Tomlinson, Igor S. Tsurupa, Anthony Tumber, Ioannis Vakonakis, Ronald P. van Rij, Laura Vangeel, Finny S. Varghese, Mariana Vaschetto, Einat B. Vitner, Vincent Voelz, Andrea Volkamer, Martin A. Walsh, Walter Ward, Charlie Weatherall, Shay Weiss, Kris M. White, Conor Francis Wild, Karolina D. Witt, Matthew Wittmann, Nathan Wright, Yfat Yahalom-Ronen, Nese Kurt Yilmaz, Daniel Zaidmann, Ivy Zhang, Hadeer Zidane, Nicole Zitzmann and Sarah N. Zvornicanin

Science, 2023, 382
DOI: 10.1126/science.abo7201

Exploring protein hotspots by optimized fragment pharmacophores

Dávid Bajusz, Warren S. Wade, Grzegorz Satała, Andrzej J. Bojarski, Janez Ilaš, Jessica Ebner, Florian Grebien, Henrietta Papp, Ferenc Jakab, Alice Douangamath, Daren Fearon, Frank von Delft, Marion Schuller, Ivan Ahel, Amanda Wakefield, Sándor Vajda, János Gerencsér, Péter Pallai and György M. Keserű

Nat Commun, 2021, 12
DOI: 10.1038/s41467-021-23443-y

Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19

Martin A. Redhead, C. David Owen, Lennart Brewitz, Amelia H. Collette, Petra Lukacik, Claire Strain-Damerell, Sean W. Robinson, Patrick M. Collins, Philipp Schäfer, Mark Swindells, Chris J. Radoux, Iva Navratilova Hopkins, Daren Fearon, Alice Douangamath, Frank von Delft, Tika R. Malla, Laura Vangeel, Thomas Vercruysse, Jan Thibaut, Pieter Leyssen, Tu-Trinh Nguyen, Mitchell Hull, Anthony Tumber, David J. Hallett, Christopher J. Schofield, David I. Stuart, Andrew L. Hopkins and Martin A. Walsh

Sci Rep, 2021, 11
DOI: 10.1038/s41598-021-92416-4

Characterization of the SARS-CoV-2 ExoN (nsp14ExoN–nsp10) complex: implications for its role in viral genome stability and inhibitor identification

Hannah T Baddock, Sanja Brolih, Yuliana Yosaatmadja, Malitha Ratnaweera, Marcin Bielinski, Lonnie P Swift, Abimael Cruz-Migoni, Haitian Fan, Jeremy R Keown, Alexander P Walker, Garrett M Morris, Jonathan M Grimes, Ervin Fodor, Christopher J Schofield, Opher Gileadi and Peter J McHugh

Nucleic Acids Research, 2022, 50, 1484
DOI: 10.1093/nar/gkab1303

Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine

Tika R. Malla, Lennart Brewitz, Dorian-Gabriel Muntean, Hiba Aslam, C. David Owen, Eidarus Salah, Anthony Tumber, Petra Lukacik, Claire Strain-Damerell, Halina Mikolajek, Martin A. Walsh and Christopher J. Schofield

J. Med. Chem., 2022, 65, 7682
DOI: 10.1021/acs.jmedchem.1c02214

Covalent adduction of serotonin-derived quinones to the SARS-CoV-2 main protease expressed in a cultured cell

Yoji Kato, Asahi Sakanishi, Kaoru Matsuda, Mai Hattori, Ichiro Kaneko, Miyu Nishikawa and Shinichi Ikushiro

Free Radical Biology and Medicine, 2023, 206, 74
DOI: 10.1016/j.freeradbiomed.2023.06.018

Binding Studies of the Prodrug HAO472 to SARS-Cov-2 Nsp9 and Variants

Miaomiao Liu, Dene R. Littler, Jamie Rossjohn and Ronald J Quinn

ACS Omega, 2022, 7, 7327
DOI: 10.1021/acsomega.1c07186

In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking

Luis Heriberto Vázquez-Mendoza, Humberto L. Mendoza-Figueroa, Juan Benjamín García-Vázquez, José Correa-Basurto and Jazmín García-Machorro

IJMS, 2022, 23, 3987
DOI: 10.3390/ijms23073987

β-Lactams and Ureas as Cross Inhibitors of Prokaryotic Systems

Monika I. Konaklieva and Balbina J. Plotkin

Applied Microbiology, 2023, 3, 605
DOI: 10.3390/applmicrobiol3030043

Potent β-lactam-based tyrosyl-DNA phosphodiesterase 1 inhibitors identified by a virtual screen

Xue Zhi Zhao, Wenjie Wang, Kiall F. Suazo, Md Rasel Al Mahmud, Keli Agama, George T. Lountos, Thorkell Andresson, Yves Pommier and Terrence R. Burke

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-12503-8

Accelerating drug target inhibitor discovery with a deep generative foundation model

Vijil Chenthamarakshan, Samuel C. Hoffman, C. David Owen, Petra Lukacik, Claire Strain-Damerell, Daren Fearon, Tika R. Malla, Anthony Tumber, Christopher J. Schofield, Helen M.E. Duyvesteyn, Wanwisa Dejnirattisai, Loic Carrique, Thomas S. Walter, Gavin R. Screaton, Tetiana Matviiuk, Aleksandra Mojsilovic, Jason Crain, Martin A. Walsh, David I. Stuart and Payel Das

Sci. Adv., 2023, 9
DOI: 10.1126/sciadv.adg7865

De novo Design of SARS-CoV-2 Main Protease Inhibitors

Christian Fischer, Nynke A. Vepřek, Zisis Peitsinis, Klaus-Peter Rühmann, Chao Yang, Jessica N. Spradlin, Dustin Dovala, Daniel K. Nomura, Yingkai Zhang and Dirk Trauner

Synlett, 2022, 33, 458
DOI: 10.1055/a-1582-0243

Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease

Siegfried T. D. Thun‐Hohenstein, Timothy F. Suits, Tika R. Malla, Anthony Tumber, Lennart Brewitz, Hani Choudhry, Eidarus Salah and Christopher J. Schofield

ChemMedChem, 2022, 17
DOI: 10.1002/cmdc.202100582

Rapid planning and analysis of high-throughput experiment arrays for reaction discovery

Babak Mahjour, Rui Zhang, Yuning Shen, Andrew McGrath, Ruheng Zhao, Osama G. Mohamed, Yingfu Lin, Zirong Zhang, James L. Douthwaite, Ashootosh Tripathi and Tim Cernak

Nat Commun, 2023, 14
DOI: 10.1038/s41467-023-39531-0

Expanding the Repertoire of Low‐Molecular‐Weight Pentafluorosulfanyl‐Substituted Scaffolds

Arathy Jose, Daniel Guest, Remi LeGay, Graham J. Tizzard, Simon J. Coles, Mariliza Derveni, Edward Wright, Lester Marrison, Alpha A. Lee, Aaron Morris, Matt Robinson, Frank von Delft, Daren Fearon, Lizbé Koekemoer, Tetiana Matviuk, Anthony Aimon, Christopher J. Schofield, Tika R. Malla, Nir London, Barnaby W. Greenland, Mark C. Bagley, John Spencer and The Covid Moonshot Consortium

ChemMedChem, 2022, 17
DOI: 10.1002/cmdc.202100641

Beta-Lactamases Inhibitors: A Perspective on the Existing and the Potential Admixtures to Synergize Beta-lactams Versus Resistant Superbugs

Abdel-Nasser El-Shorbagi, Sachin Chaudhary, Anurag Chaudhary, Garima Agarwal, Prabhash Nath Tripathi and Shweta Dumoga

Biomed. Pharmacol. J., 2022, 15, 1797
DOI: 10.13005/bpj/2519

Structural biology of SARS-CoV-2 Mpro and drug discovery

Yinkai Duan, Haofeng Wang, Zhenghong Yuan and Haitao Yang

Current Opinion in Structural Biology, 2023, 82, 102667
DOI: 10.1016/j.sbi.2023.102667

Dibenzoxanthene-β-lactam hybrids as potential antioxidant and anticancer agents: Synthesis, biological evaluation, and docking study

Somayeh Ranjbari, Aliasghar Jarrahpour, Roghayeh Heiran, Saghi Sepehri, Sedigheh Kianpour and Younes Ghasemi

Journal of Molecular Structure, 2025, 1322, 140455
DOI: 10.1016/j.molstruc.2024.140455

In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease

Takashi Miura, Tika R. Malla, C. David Owen, Anthony Tumber, Lennart Brewitz, Michael A. McDonough, Eidarus Salah, Naohiro Terasaka, Takayuki Katoh, Petra Lukacik, Claire Strain-Damerell, Halina Mikolajek, Martin A. Walsh, Akane Kawamura, Christopher J. Schofield and Hiroaki Suga

Nat. Chem., 2023, 15, 998
DOI: 10.1038/s41557-023-01205-1

Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies

Dóra Laczi, Sofia Schönbauer Huamán, Taylah Andrews-Clark, Stephen M. Laidlaw, Eidarus Salah, Leo Dumjahn, Petra Lukacik, Hani Choudhry, Martin A. Walsh, Miles W. Carroll, Christopher J. Schofield and Lennart Brewitz

European Journal of Medicinal Chemistry, 2025, 291, 117603
DOI: 10.1016/j.ejmech.2025.117603

Hydroxamate and thiosemicarbazone: Two highly promising scaffolds for the development of SARS-CoV-2 antivirals

Yin-Sui Xu, Jia-Zhu Chigan, Jia-Qi Li, Huan-Huan Ding, Le-Yun Sun, Lu Liu, Zhenxin Hu and Ke-Wu Yang

Bioorganic Chemistry, 2022, 124, 105799
DOI: 10.1016/j.bioorg.2022.105799

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine

Lennart Brewitz, Leo Dumjahn, Yilin Zhao, C. David Owen, Stephen M. Laidlaw, Tika R. Malla, Dung Nguyen, Petra Lukacik, Eidarus Salah, Adam D. Crawshaw, Anna J. Warren, Jose Trincao, Claire Strain-Damerell, Miles W. Carroll, Martin A. Walsh and Christopher J. Schofield

J. Med. Chem., 2023, 66, 2663
DOI: 10.1021/acs.jmedchem.2c01627

Efficacy of Ceftazidime and Cefepime in the Management of COVID-19 Patients: Single Center Report from Egypt

Ragaey A. Eid, Marwa O. Elgendy, Ahmed O. El-Gendy, Sara O. Elgendy, Lassaad Belbahri, Ahmed M. Sayed and Mostafa E. Rateb

Antibiotics, 2021, 10, 1278
DOI: 10.3390/antibiotics10111278

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease

Thales Kronenberger, Stefan A. Laufer and Thanigaimalai Pillaiyar

Drug Discovery Today, 2023, 28, 103579
DOI: 10.1016/j.drudis.2023.103579

Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors

Daniels Jelisejevs, Anna Lina Bula and Linda Kinena

Bioorganic & Medicinal Chemistry Letters, 2023, 96, 129530
DOI: 10.1016/j.bmcl.2023.129530

Recent breakthroughs in synthetic small molecules targeting SARS-CoV-2 Mpro from 2022 to 2024

Laura Braconi, Alice Sosic and Letizia Crocetti

Bioorganic & Medicinal Chemistry, 2025, 128, 118247
DOI: 10.1016/j.bmc.2025.118247